Logo image
Dexamethasone Suppression Test in Children with Major Depressive Disorder
Journal article   Open access

Dexamethasone Suppression Test in Children with Major Depressive Disorder

BORIS Birmaher, NEAL D. Ryan, RONALD Dahl, HARRIS Rabinovich, PAUL Ambrosini, DOUGLAS E. Williamson, HANA Novacenko, BEVERLY Nelson, EE SING LO, JOAQUIM PUIG-ANTICH, …
Journal of the American Academy of Child and Adolescent Psychiatry, v 31(2)
Mar 1992
PMID: 1564032
url
https://doi.org/10.1097/00004583-199203000-00017View
Published, Version of Record (VoR)CC BY-NC-ND V4.0 Open

Abstract

children cortisol depression dexamethasone suppression test serum dexamethasone levels
The authors report a study of 24-hour serial cortisol determinations, measured during baseline and after the administration of 0.25 and 0.5 mg of dexamethasone in a sample of predominantly outpatient children with major depressive disorder, nonaffective psychiatric controls, and normal controls. In this sample, 24-hour baseline cortisol and the dexamethasone suppression test (DST) do not discriminate between the three groups. In addition, the authors measured 24-hour serum dexamethasone levels. There were no significant between group differences in serum dexamethasone. These results raise questions as to the utility of this test in the diagnosis of affective disorders in children. Possible reasons for the discrepancies in the dexamethasone suppression test results between in- and outpatient studies are discussed.

Metrics

9 Record Views
32 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Pediatrics
Psychiatry
Psychology, Developmental
Logo image